Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» dostarlimab
dostarlimab
FDA approves GSK drug for endometrial cancer with specific genetic signature
MedCity News
Thu, 04/22/21 - 11:30 pm
GSK
Jemperli
dostarlimab
FDA
endometrial cancer
Glaxo joins the Covid-19 delay queue
EP Vantage
Wed, 01/20/21 - 10:50 am
GSK
dostarlimab
COVID-19
FDA
pandemic
endometrial cancer
GlaxoSmithKline Keeps Oncology 2.0 Growth Plans on Track
Xconomy
Sat, 06/13/20 - 11:27 pm
GSK
oncology
Zejula
niraparib
belantamab mafodotin
dostarlimab
immuno-oncology
GSK posts middling data from PD-1 Tesaro buyout drug
Fierce Biotech
Fri, 04/24/20 - 11:00 am
GSK
Tesaro
dostarlimab
clinical trials
endometrial cancer
Will GSK/Tesaro’s Checkpoint Inhibitor Be Able to Compete With Merck’s Keytruda?
BioSpace
Wed, 03/20/19 - 12:27 pm
GSK
Tesaro
Merck
Keytruda
endometrial cancer
dostarlimab